Verma M, Murthy V V, Mathew S, Banerji D, Kurl R N, Olnes M J, Yankaskas J R, Blass C, Davidson E A
Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007, USA.
Glycoconj J. 1996 Oct;13(5):797-807. doi: 10.1007/BF00702344.
The mucin gene is up-regulated in diseases such as cystic fibrosis (CF) and asthma. To understand the mechanisms involved in transcriptional regulation of mucin gene expression we have characterized the region of the mucin gene up-stream of the transcriptional start site and analysed the cis-acting elements required for mucin promoter activity. We isolated clones from a dog genomic library containing the promoter region for the tracheobronchial mucin gene (TBM). The authenticity of the promoter was tested by nucleotide sequencing, primer extension analysis, electrophoretic mobility shift assay (EMSA) and reporter gene expression analysis. The canine TBM promoter is different from housekeeping gene promoters (as it is not rich in GC content and contains TATA- and CAAT-like sequences) and different from that of regulatory genes (because it contains many TATA- and CAAT-like sequences and multiple transcriptional initiation sites). Reporter gene analysis using canine TBM promoter-chloramphenicol acetyltransferase (CAT) fusion plasmids established the regions responsible for promoter activity and verified the positions of the major mucin transcriptional initiation sites. Reporter gene analysis also established that a region of the canine TBM promoter and first exon containing all of the transcriptional initiation sites is more active in mucin expressing cells (e.g. CT1 cells-immortalized canine tracheal epithelial cells, human CFT1 cells-immortalized tracheal epithelial cells from a CF subject, or HBE1 cells-immortalized tracheal epithelial cells from non-CF subject) than in mucin non-expressing cells (COS7, 3T3), suggesting cell specificity. The promoter region contained cAMP response element (CRE) sequences, and the TBM gene transcription was enhanced when cAMP analogs were added to transfected cells. EMSA indicated the presence of at least two DNA binding proteins in CT1 cells. This is the first report describing the characterization of a TBM gene promoter. The information obtained in the present studies will be valuable in understanding mucin gene regulation in normal and pathological conditions.
黏蛋白基因在诸如囊性纤维化(CF)和哮喘等疾病中上调。为了解黏蛋白基因表达转录调控所涉及的机制,我们对转录起始位点上游的黏蛋白基因区域进行了特征分析,并分析了黏蛋白启动子活性所需的顺式作用元件。我们从犬基因组文库中分离出包含气管支气管黏蛋白基因(TBM)启动子区域的克隆。通过核苷酸测序、引物延伸分析、电泳迁移率变动分析(EMSA)和报告基因表达分析对启动子的真实性进行了测试。犬TBM启动子与管家基因启动子不同(因为它的GC含量不高且含有类TATA和类CAAT序列),也与调控基因启动子不同(因为它含有许多类TATA和类CAAT序列以及多个转录起始位点)。使用犬TBM启动子-氯霉素乙酰转移酶(CAT)融合质粒进行的报告基因分析确定了负责启动子活性的区域,并验证了主要黏蛋白转录起始位点的位置。报告基因分析还表明,犬TBM启动子和包含所有转录起始位点的第一个外显子的区域在黏蛋白表达细胞(如CT1细胞 - 永生化犬气管上皮细胞、人CFT1细胞 - 来自CF患者的永生化气管上皮细胞或HBE1细胞 - 来自非CF患者的永生化气管上皮细胞)中比在黏蛋白非表达细胞(COS7、3T3)中更具活性,表明具有细胞特异性。启动子区域包含cAMP反应元件(CRE)序列,当将cAMP类似物添加到转染细胞中时,TBM基因转录增强。EMSA表明CT1细胞中存在至少两种DNA结合蛋白。这是第一份描述TBM基因启动子特征的报告。本研究中获得的信息对于理解正常和病理条件下的黏蛋白基因调控将是有价值的。